Edward Doo

11.0k citations
44 papers · 6.8k · 5 hit papers · h-index 26

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
  • Epidemiology top 0.2%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Liver Disease Diagnosis and Treatment 22
    • Hepatitis B Virus Studies 20
    • Hepatitis C virus research 18
    • Hepatitis Viruses Studies and Epidemiology 5
    • Liver Disease and Transplantation 3

Edward Doo

44 papers receiving 6.6k citations

Edward Doo's Hit Papers

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease 2018 · 466 citations
4660+7+14Years since publication50010001.5k

Peers

Edward Doo
Comparison fields: 5 of 107
  • Hepatology 2.7k
  • Epidemiology 4.6k
  • Endocrinology, Diabetes and Metabolism 958
  • Pharmacology 376
  • Surgery 861
Replace Bilal Hameed with:
Bilal Hameed United States
Hari S. Conjeevaram United States
Andreas Geier Germany
Naga Chalasani United States
Lawrence Serfaty France
Yasuji Arase Japan
Katsutoshi Tokushige Japan
Aleksander Krag Denmark
Yuichiro Eguchi Japan
Coleman I. Smith United States
Edward Doo relative to Bilal Hameed United States Bilal Hameed's profile →
Citations per field
00.5×1.5×1.9×
Bilal Hameed · 1×
Citations per year

Countries citing papers authored by Edward Doo

Since Specialization
Citations

This map shows the geographic impact of Edward Doo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Doo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Doo more than expected).

Fields of papers citing papers by Edward Doo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Doo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Doo. The network helps show where Edward Doo may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward Doo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Doo Line = papers co-authored together Edward Doo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Hit paper breakdown →
20141758
2
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡
Hit paper breakdown →
2004588
3
Acute liver failure
Hit paper breakdown →
2008524
4 2007471
5
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
Hit paper breakdown →
2018466
6 2003299
7 2000289
8
Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century
Hit paper breakdown →
2018228
9 2017209
10 1999193
11 2017191
12 2009173
13 2006168
14 2002147
15 2013147
16 2017116
17 2009114
18 1999106
19 200377
20 201974

About Edward Doo

Edward Doo is a scholar working on Epidemiology, Hepatology, Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery, having authored 44 papers that have together received 6.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (18 papers), Hepatitis Viruses Studies and Epidemiology (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Silymarin and Mushroom Poisoning (3 papers), HIV/AIDS drug development and treatment (3 papers) and Liver Disease and Transplantation (3 papers). The work is most often cited by research in Hepatology (2.7k citations), Epidemiology (4.6k citations), Endocrinology, Diabetes and Metabolism (958 citations), Pharmacology (376 citations) and Surgery (861 citations). Edward Doo has collaborated with scholars based in United States, Malaysia and Russia. Frequent co-authors include Jay H. Hoofnagle, David E. Kleiner, Marc G. Ghany, T. Jake Liang, Arun J. Sanyal, Rohit Loomba, Brent A. Neuschwander‐Tetri, Mark L. Van Natta, James Tonascia and Kris V. Kowdley. Their work appears in journals such as Hepatology, Gastroenterology, Journal of Hepatology, Alimentary Pharmacology & Therapeutics and Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact